CPA
ENZ

Clear Point Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Clear Point Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-120
Closed -$134 – 568
2024
Q3 		$134 Hold
120
– – ﹤0.01% 540
2024
Q2 		$131 Hold
120
– – ﹤0.01% 539
2024
Q1 		$152 Hold
120
– – ﹤0.01% 536
2023
Q4 		$167 Buy
+120
New +$159 ﹤0.01% 521

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Clear Point Advisors's ENZ Position: Q4 2024 in Review

Clear Point Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2024, closing a stake of 120 shares — an estimated $134 sold.

Clear Point Advisors first reported a position in ENZ in Q4 2023 and held it in 4 quarters. The position peaked at $167 in Q4 2023. 45 funds tracked by Wall St. Rank hold ENZ as of Q4 2024.

  • Clear Point Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2024 after selling out during the quarter.
  • Clear Point Advisors sold 120 Enzo Biochem, Inc. shares in Q4 2024, an estimated $134.
  • Clear Point Advisors first reported a position in Enzo Biochem, Inc. in Q4 2023 and held it in 4 quarters.
  • Clear Point Advisors's Enzo Biochem, Inc. position peaked at $167 in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2024.

Based on Clear Point Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.